Investors

Analyst Coverage

  • Matt Luchini

    BMO
    • Edward Nash

      Canaccord Genuity
      • Michael Morabito

        Chardan
        • Joel Beatty

          Citi
          • Ritu Baral

            Cowen
            • Josh Schimmer M.D.

              Evercore ISI
              • Ross Weinreb

                Goldman Sachs
                • Ed Arce

                  HC Wainwright
                  • Jonathan Wolleben

                    JMP Securities
                    • Jay Olson

                      Oppenheimer
                      • Yasmeen Rahimi

                        Piper Sandler
                        • Steve Seedhouse

                          Raymond James & Associates
                          • Mayank Mamtani

                            B Riley FBR
                            • Roth Capital Partners
                              • Derek Archila

                                Stifel
                                • Thomas Smith

                                  SVB Leerink
                                  • Navin Jacob

                                    UBS
                                    • Akash Tewari

                                      Wolfe Research

                                      Madrigal Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Madrigal Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Madrigal Pharmaceuticals, Inc. or its management. Madrigal Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.